EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer

Yang Feng iD, Qingchen Yuan iD, Rachel C Newsome iD, Troy Robinson iD, Robert L Bowman iD, Ashley N Zuniga iD, Kendra N Hall iD, Cassandra M Bernsten iD, Daniil E Shabashvili iD, Kathryn I Krajcik iD, Chamara Gunaratne iD, Zachary J Zaroogian iD und 10 weitere

Journal of Experimental Medicine · 2023

DOI: 10.1084/jem.20230011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2023. Verfasst von Yang Feng und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, University of FloridaCollege of Medicine, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Colitis-Associated Neoplasms, Colonic Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal hematopoiesis (CH) is defined as clonal expansion of mutant hematopoietic stem cells absent diagnosis of a hematologic malignancy. Presence of CH in solid tumor patients, including colon cancer, correlates with shorter survival. We hypothesized that bone marrow–derived cells with heterozygous loss-of-function mutations of DNMT3A, the most common genetic alteration in CH, contribute to the pathogenesis of colon cancer. In a mouse model that combines colitis-associated colon cancer (CAC) with experimental CH driven by Dnmt3a+/Δ, we found higher tumor penetrance and increased tumor burden compared with controls. Histopathological analysis revealed accentuated colonic epithelium injury, dysplasia, and adenocarcinoma formation. Transcriptome profiling of colon tumors identified enrichment of gene signatures associated with carcinogenesis, including angiogenesis. Treatment with the angiogenesis inhibitor axitinib eliminated the colon tumor-promoting effect of experimental CH driven by Dnmt3a haploinsufficiency and rebalanced hematopoiesis. This study provides conceptually novel insights into non-tumor-cell-autonomous effects of hematopoietic alterations on colon carcinogenesis and identifies potential therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis-Associated NeoplasmsColonic NeoplasmsAnimalsMiceCarcinogenesisLoss of HeterozygosityMutationDNA Methyltransferase 3A

Substanzen

Dnmt3a protein, mouseDNA Methyltransferase 3A

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, University of FloridaCollege of Medicine, Gainesville, FL, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of FloridaCollege of Medicine, Gainesville, FL, USA.
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Anatomy and Cell Biology, University of FloridaCollege of Medicine, Gainesville, FL, USA.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Interdisciplinary Center for Biotechnology Research, University of Florida , Gainesville, FL, USA.

ORCID-Profile: Yang Feng, Qingchen Yuan, Rachel C Newsome, Troy Robinson, Robert L Bowman, Ashley N Zuniga, Kendra N Hall, Cassandra M Bernsten, Daniil E Shabashvili, Kathryn I Krajcik, Chamara Gunaratne, Zachary J Zaroogian, Kartika Venugopal, Heidi L Casellas Roman, Ross L Levine, Walid K Chatila, Rona Yaeger, Alberto Riva, Christian Jobin, Daniel Kopinke, Dorina Avram, Olga A Guryanova

Förderung

  • NIAMS NIH HHS
  • NCI NIH HHS
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • Thomas H. Maren Junior Investigator
  • Harry T. Mangurian, Jr. Foundation
  • UF Health Cancer Center

Zitieren

APA

Feng, Y., Yuan, Q., Newsome, R. C., Robinson, T., Bowman, R. L., Zuniga, A. N., Hall, K. N., Bernsten, C. M., Shabashvili, D. E., Krajcik, K. I., Gunaratne, C., Zaroogian, Z. J., Venugopal, K., Casellas Roman, H. L., Levine, R. L., Chatila, W. K., Yaeger, R., Riva, A., Jobin, C., …, & Guryanova, O. A. (2023). Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20230011

Vancouver

Feng Y, Yuan Q, Newsome RC, Robinson T, Bowman RL, Zuniga AN, et al. Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer. Journal of Experimental Medicine. 2023. doi:10.1084/jem.20230011

BibTeX
@article{Feng2023,
  author = {Feng, Yang and Yuan, Qingchen and Newsome, Rachel C and Robinson, Troy and Bowman, Robert L and Zuniga, Ashley N and Hall, Kendra N and Bernsten, Cassandra M and Shabashvili, Daniil E and Krajcik, Kathryn I and Gunaratne, Chamara and Zaroogian, Zachary J and Venugopal, Kartika and Casellas Roman, Heidi L and Levine, Ross L and Chatila, Walid K and Yaeger, Rona and Riva, Alberto and Jobin, Christian and Kopinke, Daniel and Avram, Dorina and Guryanova, Olga A},
  title = {Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer},
  journal = {Journal of Experimental Medicine},
  year = {2023},
  doi = {10.1084/jem.20230011}
}
Kostenlos starten →